Workflow
歌尔股份_2025 年第三季度业绩符合预期;维持买入评级,因其为 XR 领域受益标的_
2025-10-31 00:59
GoerTek (002241.SZ) 3Q25 Earnings Call Summary Company Overview - GoerTek is a manufacturer of acoustic components and accessory products for consumer electronics, including tablets, PCs, and smartphones. The company has established long-term partnerships with leading consumer-electronic brands due to its expertise in miniature acoustics components and execution strength [26][27]. Key Financial Highlights - **3Q25 Revenue**: Rmb30.6 billion, up 4% YoY and 44% QoQ, exceeding CitiE and BBGe estimates by 17% and 11% respectively [2][3]. - **Gross Margin (GM)**: Improved by 1.5 percentage points YoY to 12.8%, slightly below CitiE but above BBGe [2][3]. - **Operating Profit (OP)**: Rmb1.4 billion, a 10% increase YoY, in line with CitiE and beating BBGe by 12% [2][3]. - **Net Profit (NP)**: Rmb1.2 billion, up 5% YoY, exceeding CitiE by 6% but missing BBGe by 5% [2][3]. - **Gross Profit (GP)**: Increased by 18% YoY to Rmb3.9 billion, beating both CitiE and BBGe estimates [2][3]. Earnings Forecast and Target Price - **Revised EPS Estimates**: 2025-2027 EPS estimates increased by 1%, 6%, and 6% respectively, reflecting positive contributions from smart hardware and AI glasses [3][17]. - **New Target Price**: Increased to Rmb38.0 from Rmb34.0, based on a 28.2x P/E for 2026, indicating confidence in the emerging XR business [3][28]. Strategic Insights - GoerTek is expected to benefit from the iPhone MEMS microphone upgrade and the anticipated growth in AI smart glasses, particularly in the US and China [3][27]. - The smart hardware segment is projected to rebound in 2026/27, driven by AI smart glasses and VR/MR recovery [13][14]. Market Position and Risks - **Market Cap**: Rmb116.2 billion (approximately US$16.3 billion) [4]. - **Investment Rating**: Rated as "Buy" with an expected total return of 15.4%, including a 14.2% price return and a 1.3% dividend yield [4][27]. - **Risks**: Potential risks include lower-than-expected VR/AR penetration rates and increased competition leading to price pressures [29]. Conclusion - GoerTek's 3Q25 results indicate a stable performance with positive growth prospects driven by advancements in smart hardware and strategic partnerships. The upward revision of EPS estimates and target price reflects confidence in the company's future growth trajectory, particularly in the XR and AI segments [3][28].
华明装备 - A 股_业绩说明会核心要点及模型更新
2025-10-31 00:59
Summary of Huaming Equipment - A Conference Call Company Overview - **Company**: Huaming Equipment - **Industry**: Power Equipment and Utilities - **Market Position**: Largest manufacturer of tap changers for transformers in China with a market share exceeding 60% [11][16] Key Takeaways 1. **Order Growth**: The company has received significant orders from US datacenters and renewable power plants, indicating a positive trend that is expected to continue due to rising demand in these sectors [2][8] 2. **International Revenue**: The EU represents half of Huaming's overseas revenue, contributing to over 45% growth in international sales during the first nine months of the year [2][8] 3. **Middle East Expansion**: Plans to establish a plant in the Middle East to meet local requirements for indigenizing the transformer supply chain, anticipating increased sales in this region by 2027 [2][8] 4. **Domestic Demand**: While domestic growth is modest, there is an uptick in demand from the State Grid, with targets to secure orders for ultra-high voltage (UHV) transformers [2][8] 5. **Valuation and Price Target**: The price target for June 2026 has been raised from Rmb24 to Rmb28, reflecting a revised P/E multiple of approximately 28x due to improved earnings prospects [12][17] Financial Highlights - **Earnings Estimates**: Adjusted net income estimates for 2025 and 2026 have been increased by 3-6% to account for strong overseas momentum and a larger addressable market for tap changers [8][11] - **Revenue Growth**: Projected revenue growth rates are 18.4% for FY24, 5.0% for FY25, and 13.1% for FY26 [20] - **Margins**: Anticipated EBITDA margins are expected to improve from 32.3% in FY24 to 39.5% in FY27 [20] Risks and Challenges 1. **Domestic Revenue Growth**: Potential slower-than-expected growth in domestic revenue due to high base effects from State Grid's transformer tenders [18] 2. **Overseas Demand**: Risks associated with slower-than-expected growth in overseas transformer demand [18] 3. **Cost Fluctuations**: Vulnerability to fluctuations in exchange rates and freight costs, which could impact profitability [18] Additional Insights - **Operational Expenses**: An increase in operational expenses in Q3 was attributed to share incentive expenses and higher SG&A costs related to overseas expansion [8] - **Cash Flow Stability**: Despite a year-over-year decline in cash flow, management noted stable receivables collection from both domestic and international operations [8] - **Market Dynamics**: The tap changer manufacturing market has high barriers to entry, with gross margins exceeding 50%, positioning Huaming favorably for sustained growth [11][16] Conclusion - **Investment Rating**: The company maintains an Overweight (OW) rating, supported by its strong market position, growth prospects in international markets, and strategic expansion plans [11][16]
中国铝业_2025 年第三季度净利润同比增长 90%,基本符合预期;现金流和资产负债表表现强劲,维持首选评级-Aluminum Corporation of China (2600.HK)_ 3Q25 NI Up 90% YoY, Largely in Line; Very Strong Cash Flow and B_S, Maintain Top Pick
2025-10-31 00:59
Summary of Aluminum Corporation of China (Chalco) 3Q25 Earnings Call Company Overview - **Company**: Aluminum Corporation of China (Chalco) - **Stock Ticker**: 2600.HK - **Date of Report**: 27 October 2025 Key Financial Metrics - **Net Profit**: 9M25 net profit at Rmb10.87 billion, up 21% YoY, representing 81% of the 2025E Bloomberg consensus and Citi's full-year forecast [1][1] - **3Q25 Net Profit**: Rmb3.801 billion, +90% YoY and +8% QoQ, largely in line with expectations [1][1] - **Gross Profit**: 3Q25 gross profit at Rmb10.28 billion, +55% YoY and +7% QoQ, attributed to higher aluminum and alumina prices and lower production costs [1][1][3] - **Free Cash Flow (FCF)**: Increased to Rmb9.0 billion, +34% YoY and +56% QoQ [8][8] - **Operating Cash Flow (OCF)**: Rmb11.1 billion, +10% YoY and +39% QoQ [4][4] - **Net Gearing**: Improved to 19% from 30% at the end of 2024 [4][4] Production and Sales - **Alumina Production**: 5.63 million tons, +1% YoY and +7% QoQ [2][2] - **Aluminum Production**: 2.03 million tons, +2% YoY and flat QoQ [2][2] - **External Sales of Self-Produced Aluminum**: 2.04 million tons, +1% YoY and flat QoQ [2][2] Price Trends - **Alumina Spot Price**: Rmb3,148 per ton, down 20% YoY but up 3% QoQ [3][3] - **SHFE Aluminum Price**: Rmb20,717 per ton, up 6% YoY and up 3% QoQ [3][3] Valuation and Investment Outlook - **Target Price**: HK$7.47 per share, with a current price of HK$9.19, indicating an expected share price return of -18.7% [6][6] - **Expected Dividend Yield**: 3.7% [6][6] - **P/B Ratio**: 1.9x for 2025E [8][8] - **P/E Ratio**: 10.7x for 2025E [8][8] Risks - **Downside Risks**: 1. Lower-than-expected aluminum and alumina prices 2. Higher-than-expected costs 3. Higher-than-expected impairment loss 4. Potential loosening of supply cut policies by the Chinese government if aluminum prices overshoot [14][14][16][16] Conclusion - Chalco's strong financial performance in 3Q25, characterized by significant profit growth and improved cash flow, positions the company favorably for future shareholder returns. However, potential risks related to price fluctuations and government policies should be monitored closely. The investment outlook remains cautious with a maintained "Buy" rating despite the target price indicating a potential decline from current levels [1][8].
龙佰集团-2025 年第三季度 -因钛白粉营业利润率创历史新低导致业绩疲软;不可持续的钛白粉价格或触底
2025-10-31 00:59
Summary of LB Group 3Q25 Earnings Call Company Overview - **Company**: LB Group - **Industry**: Titanium Dioxide (TiO2) Production - **Market Position**: Largest manufacturer of TiO2 pigments globally, with a production capacity of 1.5 million tons per year, accounting for over 18% of total global production capacity as of 2024 [11][12]. Key Financial Highlights - **3Q25 Net Profit**: Rmb 289 million, a decrease of 66% year-over-year [1][8]. - **Revenue**: Rmb 6,109 million, down 14% year-over-year and 3% quarter-over-quarter [8]. - **Operating Income**: Rmb 382 million, a decline of 63% year-over-year [8]. - **Gross Margin Pressure**: Notable declines in gross margins for iron-based products, sponge titanium, and new energy materials [1]. Core Points and Arguments Positive Aspects - **TiO2 Price Recovery**: The TiO2 price has increased by Rmb 300 per ton since hitting a low in August [2]. - **Production Adjustments**: Smaller TiO2 producers are beginning to reduce production due to unsustainable negative operating margins [2]. Negative Aspects - **Weak TiO2 Market**: The average operating margin for the sulphate method of TiO2 production was negative Rmb 1,507 per ton in 3Q25, indicating severe financial strain across the industry [2][3]. - **Geopolitical Risks**: Ongoing tariff tensions may adversely affect LB's TiO2 export business, posing additional challenges [3]. Market Consensus and Revisions - **Consensus Earnings Estimates**: Current net profit consensus for FY25 is Rmb 2,791 million, which may be overly optimistic given the outlook for TiO2 prices and margins [4]. - **Stock Performance**: The share price has increased by 11.2% since the 2Q results, outperforming the SZCOMP Index, reflecting market expectations of a bottoming out in TiO2 margins [4]. Expected Market Reaction - **Market Sentiment**: Anticipated slightly negative reaction to 3Q25 results due to weaker-than-expected earnings and concerns over the sustainability of current TiO2 margins [5]. Risks to Investment Thesis - **Price Volatility**: Risks include a larger-than-expected decrease in TiO2 prices and higher feedstock cost inflation [13]. - **Capacity Ramp-Up**: Slower-than-expected ramp-up of new capacities could further impact financial performance [13]. Valuation - **Price Target**: Rmb 21.30, based on a 15x one-year forward P/E ratio, reflecting expectations of a recovery in TiO2 margins and steady earnings growth [12]. Conclusion LB Group is facing significant challenges in the TiO2 market, with weak earnings and pressure on margins. However, there are signs of potential recovery in TiO2 prices, and the company maintains a strong market position. Investors should be cautious of geopolitical risks and market volatility as they assess future performance.
湖南裕能Q325业绩符合预期
2025-10-31 00:59
Global Research abc 2025 年 10 月 27 日 问:相对于预期,业绩表现如何? 答:公司Q325实现收入88.7亿元 (+74% YoY / +17% QoQ),实现归母 净利润3.4亿元(+235% YoY / +61% QoQ)。符合我们预期,略低于市场一 致预期。 答:公司披露前三季度出货量78.5万吨(+65% YoY),对应Q325出货 量30.4万吨 (+18% QoQ)。据此我们测算Q325实现单吨净利润约1,070 元,加回8,000万元信用减值后对应单吨净利润约1300元,环比改善约400 元(见图1),我们认为主要受益于公司产能利用率的提升及部分二线电池 客户加工费上涨。根据鑫椤锂电数据,9月铁锂行业产能利用率达到81%, 供给相对紧缺。我们与业内专家的交谈显示9月起行业内逐步开始对二线电 池企业的加工费上调,幅度约约1,000-2,000元,与一线客户谈价仍在进行 中。近期富临精工发布公告与宁德时代共同对江西升华增资扩股,交易完成 后宁德时代将控股江西升华(股权比例51%)。我们认为该交易将进一步加 强宁德时代对上游供应商的议价权(见图2)。针对一线客户加工费上 ...
华阳集团-(买入)-2025 年第三季度交付符合预期;受订单赶工影响,第四季度或表现强劲_速评
2025-10-31 00:59
Summary of Foryou (002906.SZ) 3Q25 Earnings Call Company Overview - **Company**: Foryou (002906.SZ) - **Industry**: Technology, specifically in the automotive electronics sector Key Financial Results - **3Q25 Revenue**: CNY 3.5 billion, representing a **31% year-on-year (y-y)** growth and **23% quarter-on-quarter (q-q)** growth [1][6] - **Gross Profit Margin (GPM)**: 18.9%, a decline of **1.5 percentage points (pp) y-y** and **0.6 pp q-q** [1][6] - **Operating Profit Margin (OPM)**: 7.4%, down **0.8 pp y-y** but up **0.3 pp q-q** [1][6] - **Earnings**: CNY 220 million, an increase of **24% y-y** and **18% q-q** [1][6] Market Position and Demand - Foryou is a leader in the China Head-Up Display (HUD) market and actively participates in the cockpit components segment [2] - The company is benefiting from the fast-growing demand in the Chinese auto market, particularly due to the trend towards intelligent vehicles [2] - Anticipated strong demand in **4Q25** due to rushing orders from customers [2] Investment Outlook - **Rating**: Buy - **Target Price**: CNY 42, with the stock currently trading at CNY 30.59 [3][4] - The stock is trading at **15x** the projected **2026 EPS of CNY 2.04** [3] Focus Areas for Investors - Changes in product mix and updates on new products for **2026** - Potential new demand from Original Equipment Manufacturers (OEMs) [3] Risks and Challenges - Potential risks include weaker-than-expected demand in the Chinese auto market, increased competition from local players, and slower development of new products [16] Additional Insights - Foryou's GPM decline is attributed to low utilization at a new factory in the precision die casting business and intense competition in the auto electronics sector [1] - The company has maintained control over operating expenses, which has positively impacted OPM [1] Market Share Data - Foryou holds a **22.1% market share** in the HUD segment and **22.3% in the AR-HUD segment** as of August 2025 [8] - In cockpit display-related components, Foryou has a **4.7% market share** in integrated central control panels and **6.4% in LCD instrument clusters** [9] This summary encapsulates the key points from Foryou's 3Q25 earnings call, highlighting financial performance, market position, investment outlook, and associated risks.
北方稀土_2025 年第三季度因产品结构调整导致毛利率不及预期,维持买入评级
2025-10-31 00:59
Summary of China Northern Rare Earth High-Tech (600111.SS) 3Q25 Earnings Call Company Overview - **Company**: China Northern Rare Earth High-Tech (NRE) - **Ticker**: 600111.SS - **Industry**: Rare Earth Materials Key Financial Highlights - **Net Profit**: 9M25 net profit reached Rmb1,541 million, up 280% YoY, representing 69% of Street consensus and 71% of the full-year estimation [1][5] - **3Q25 Net Profit**: Implied net profit was Rmb610 million, up 22% QoQ and 69% YoY [1] - **Excluding One-offs**: Net profit excluding one-offs for 9M25 was Rmb1,362 million, up 412% YoY; 3Q25 net profit was Rmb467 million, up 86% YoY and 1% QoQ [1] - **Gross Profit (GP)**: 3Q25 GP was Rmb1,130 million, up 28% YoY but down 9% QoQ [1] Sales and Production Data - **Sales Volume**: 3Q25 rare earth raw materials sales volume increased by 38% YoY [2] - **Production Figures**: - Rare earth oxides: 6,939 tons, up 63% YoY - Rare earth salts: 38,635 tons, up 14% YoY - Rare earth metals: 12,197 tons, up 24% YoY [2] Margin Analysis - **GP Margin**: 3Q25 GP margin was 10%, down 0.4 percentage points YoY and down 3 percentage points QoQ, attributed to product-mix adjustments with increased share of lanthanum and cerium products [3] Inventory and Cash Flow - **Inventory Levels**: Inventory decreased by 12% QoQ to Rmb14 billion, accounting for 29% of total assets, down from 34% at the end of 1H25 [4] - **Free Cash Flow (FCF)**: 9M25 FCF was Rmb1,750 million, with 3Q FCF at Rmb1,472 million, up 45% YoY and 372% QoQ [5] Valuation Metrics - **Current Trading Multiples**: NRE is trading at 52.9x 2026E P/E and 6.8x 2026E P/B [5] - **Target Price**: Target price set at Rmb72, implying a 35.1% expected share price return [8][11] Risks and Considerations - **Demand Growth**: Risks include slower or faster-than-expected demand growth in downstream applications such as NEVs and wind power [12] - **Supply Chain Dynamics**: Potential impacts from global supply-chain diversification efforts and changes in mining or processing capacity outside of China [12] - **Policy Changes**: Risks from tariffs, trade barriers, and policy adjustments in China affecting supply and profitability [12] - **Technological Substitutes**: Emergence of alternative materials or technologies that could replace rare earth elements [12] Conclusion - The company has shown significant growth in net profit and sales volume, although margins have been impacted by product mix changes. The inventory management strategy appears effective, and the company maintains a positive cash flow. However, various risks related to demand, supply chain, and policy changes could affect future performance. The current valuation suggests a favorable outlook, supported by strong fundamentals and market conditions.
东方电气_上调至买入评级_买入_风险收益性价比突出
2025-10-31 00:59
Summary of Dongfang Electric Conference Call Company Overview - **Company**: Dongfang Electric (1072 HK/600875 CH) - **Industry**: Electrical Equipment Key Points and Arguments 1. Upgrade to Buy/Buy - Dongfang Electric's H/A shares have been upgraded to Buy/Buy from Reduce/Reduce due to improved risk/reward dynamics after a recent price cooldown. The current trading PE is 12x for 2026 estimates, which is +1 standard deviation above the past three-year mean, down from +3 standard deviations previously. This indicates a more attractive valuation compared to global peers like GE Vernova and Siemens Energy, which trade at 31-47x 2026e PE [1][8][33]. 2. Sustained Upcycle in Coal Power Equipment - The expectation for new orders and revenue from coal power equipment has shifted. The delivery cycle is extended due to tight supply, leading to an increase in installation and equipment delivery from 55GW in 2025 to 80GW in 2027. This change has prompted an increase in EPS forecasts for 2026 and 2027, indicating continued growth in this segment [2][4]. 3. Earnings Projections for 3Q25 - Dongfang Electric is projected to achieve a 20% year-over-year growth in earnings, reaching RMB1.12 billion in 3Q25, which aligns with the high end of market expectations. A Corporate Day on November 6 could serve as a catalyst for further positive guidance [3][26]. 4. Financial Estimates and Target Prices - Estimates for 2026 and 2027 have been raised by 5-27% to account for the longer delivery cycle of coal power equipment. The target prices for Dongfang H/A have been increased to HKD21.50 and RMB23.50 from HKD12.20 and RMB17.70, respectively. This reflects a 22% CAGR in EPS from 2024 to 2027, supported by strong orders in coal, nuclear, and hydro segments [4][35]. 5. Risks and Concerns - Key downside risks include potential delays in equipment delivery, rising raw material costs, and weaker-than-expected margins in the wind turbine segment. These factors could impact the overall growth trajectory of the company [4][36]. Additional Important Information - The share prices of Dongfang Electric have corrected significantly after an initial surge due to the Yarlung Zangbo project announcement, falling 36%/21% from late July to late September. The current valuation is now seen as attractive again, with a projected earnings CAGR of 22% [19][22]. - The company is expected to maintain a strong cash flow from operations, with net profit estimates for 2026 and 2027 revised upwards significantly [28][29]. This summary encapsulates the critical insights from the conference call regarding Dongfang Electric's current market position, financial outlook, and potential risks, providing a comprehensive overview for investors.
药明康德_Q325 业绩超预期并上调指引;剥离 CRO_SMO 业务聚焦 CRDMO
2025-10-31 00:59
Summary of Wuxi Apptec Conference Call Company Overview - **Company**: Wuxi Apptec - **Industry**: Pharmaceutical R&D services - **Market Position**: Largest chemical drug contract research, development, and manufacturing organization (CRDMO) in China [12][13] Key Financial Highlights - **Q3 2025 Performance**: - Revenue: Rmb12.1 billion, up 15.3% YoY and 8.2% QoQ, exceeding estimates [2] - Net Profit: Rmb3.5 billion, up 53.3% YoY, also beating estimates [2] - Adjusted non-IFRS net profit: Rmb4.2 billion, up 42.0% YoY [2] - Adjusted non-IFRS gross margin: 44.5%, improved by 6.1 percentage points YoY [2] - Backlog for continuing operations: Rmb59.9 billion, a strong 41.2% YoY increase [2] Business Segment Performance - **Wuxi Chemistry**: - Revenue: Rmb9.7 billion, up 15.3% YoY and 8.6% QoQ - TIDES business revenue: Rmb2.8 billion, up 91.2% YoY, contributing 29% to Wuxi Chemistry revenue [3] - TIDES backlog: Increased by 17.1% YoY [3] - **Wuxi Testing**: - Revenue: Rmb1.5 billion, up 2.1% YoY and 6.1% QoQ - CRO/SMO segment revenue: Down 6.4% YoY [3] - **Wuxi Biology**: - Revenue: Rmb696 million, up 5.9% YoY [3] Geographic Performance - **US Market**: Key growth driver with revenue up 31.9% YoY to Rmb22.2 billion [3] - **Europe**: Revenue increased by 13.5% YoY to Rmb3.8 billion [3] - **China**: Returned to positive growth with revenue of Rmb5.0 billion, up 0.5% YoY [3] Future Guidance and Strategic Moves - **Revenue Guidance for 2025**: Raised from Rmb42.5-43.5 billion to Rmb43.5-44.0 billion [4] - **Continuing Revenue Growth Guidance**: Increased from 13%-17% to 17%-18% YoY [4] - **Divestiture**: Announced divestiture of clinical CRO/SMO business for Rmb2.8 billion, allowing focus on core CRDMO business [4] Valuation and Investment Outlook - **Price Target**: Increased to HK$138.4 from HK$136.1, rated as "Buy" [5] - **EPS Forecast Adjustments**: Increased by 23.4% for 2025, with slight adjustments for subsequent years [5][10] - **Market Capitalization**: Approximately HK$326 billion (US$42.0 billion) [7] Risks and Considerations - **Key Risks**: Include potential project delays, geopolitical uncertainties, and lower-than-expected R&D spending by pharmaceutical companies [13] - **Market Sentiment**: Positive outlook with expectations of improved global biopharma funding [15] Additional Insights - **Analyst Ratings**: 12-month rating of "Buy" with a forecast stock return of 27.1% [11][19] - **Market Performance**: Stock price as of October 24, 2025, was HK$110.50, within a 52-week range of HK$121.40-45.65 [7]
光迅科技-买入-2025 年第三季度营收环比增长,利润率上升
2025-10-31 00:59
Summary of Accelink's 3Q25 Earnings Call Company Overview - **Company**: Accelink (Ticker: 002281.SZ) - **Sector**: Technology - **Date of Earnings Report**: 24 October 2025 Key Financial Highlights - **Revenue Growth**: - 3Q25 revenue increased by 45.0% year-over-year (y-y) and 8.9% quarter-over-quarter (q-q) to CNY 3.29 billion - 9M25 revenue growth was 58.65% y-y, with earnings growth at 54.95% y-y [1][2] - **Earnings Performance**: - 3Q25 earnings increased by 35.8% y-y and 56.0% q-q, reaching CNY 347 million - Adjusted operating margin improved by 0.2 percentage points (pp) y-y and 4.8 pp q-q [1][5] - **Gross Margin**: - Gross margin decreased by 1 pp y-y but increased by 3.9 pp q-q due to a better product mix in the optical transceivers sector [1][5] - **Operating Cash Flow**: - Strong performance with operating cash flow reaching CNY 1.08 billion in 9M25, a 206.64% increase y-y [1] Market and Industry Insights - **Demand Trends**: - Notable uptick in demand for optical transceivers in the global Automatic Identification and Data Capture (AIDC) market - Large Chinese Cloud Service Providers (CSPs) are investing in AI infrastructure, positioning Accelink to benefit from this trend [2] - **Future Growth Projections**: - Estimated 53% revenue compound annual growth rate (CAGR) from the optical transceivers segment for FY25-27F, expected to contribute 49% of total revenue by FY27F [2] Investment Outlook - **Rating and Target Price**: - Maintained "Buy" rating with a target price of CNY 80, based on a price-to-earnings (P/E) ratio of 43x FY26F earnings per share (EPS) of CNY 1.87 [2][3] - **Current Stock Valuation**: - Stock trading at 33.8x FY26F EPS, indicating potential upside [2] Risks and Challenges - **Potential Risks**: - Lower-than-expected demand for optical components from the datacom and telecom markets - Slower-than-anticipated R&D progress on optical chipsets - Increased pricing competition leading to margin dilution - Potential sanctions affecting the technology sector [12] Additional Information - **Analysts**: Bing Duan and Ethan Zhang from Nomura International (Hong Kong) Ltd. [4] - **Closing Price on Report Date**: CNY 63.23 [3]